These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33621446)

  • 21. Angiotensin receptor-neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime.
    Arcudi A; Di Francesco M; Rodolico D; D'Amario D
    ESC Heart Fail; 2022 Oct; 9(5):3639-3642. PubMed ID: 35712811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral infarction in Duchenne muscular dystrophy.
    Tsakadze N; Katzin LW; Krishnan S; Behrouz R
    J Stroke Cerebrovasc Dis; 2011; 20(3):264-5. PubMed ID: 20621521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of myocardial damage in muscular dystrophy].
    Tamura T
    Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.
    Kajimoto H; Ishigaki K; Okumura K; Tomimatsu H; Nakazawa M; Saito K; Osawa M; Nakanishi T
    Circ J; 2006 Aug; 70(8):991-4. PubMed ID: 16864930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.
    Doing AH; Renlund DG; Smith RA
    J Heart Lung Transplant; 2002 Apr; 21(4):496-8. PubMed ID: 11927228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy.
    Cheng VE; Prior DL
    Heart Lung Circ; 2013 Aug; 22(8):677-81. PubMed ID: 23279916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy.
    Stalens C; Motté L; Béhin A; Ben Yaou R; Leturcq F; Bassez G; Laforêt P; Fontaine B; Ederhy S; Masingue M; Saadi M; Louis SL; Berber N; Stojkovic T; Duboc D; Wahbi K
    J Neuromuscul Dis; 2021; 8(4):495-502. PubMed ID: 33814458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.
    Yu HK; Xia B; Liu X; Han C; Chen W; Li Z
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):67-76. PubMed ID: 30105418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Levine TB; Levine AB; Keteyian SJ; Narins B
    Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
    Fayssoil A
    Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left Ventricular Magnetic Resonance Imaging Strain Predicts the Onset of Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
    Siddiqui S; Alsaied T; Henson SE; Gandhi J; Patel P; Khoury P; Villa C; Ryan TD; Wittekind SG; Lang SM; Taylor MD
    Circ Cardiovasc Imaging; 2020 Nov; 13(11):e011526. PubMed ID: 33190531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotection for Duchenne's muscular dystrophy.
    Ishikawa Y; Bach JR; Minami R
    Am Heart J; 1999 May; 137(5):895-902. PubMed ID: 10220639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental cost-effectiveness of guideline-directed medical therapies for heart failure.
    Banka G; Heidenreich PA; Fonarow GC
    J Am Coll Cardiol; 2013 Apr; 61(13):1440-6. PubMed ID: 23433562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study.
    Wong M; Staszewsky L; Latini R; Barlera S; Volpi A; Chiang YT; Benza RL; Gottlieb SO; Kleemann TD; Rosconi F; Vandervoort PM; Cohn JN;
    J Am Coll Cardiol; 2002 Sep; 40(5):970-5. PubMed ID: 12225725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx Mice.
    Blain A; Greally E; Laval SH; Blamire AM; MacGowan GA; Straub VW
    J Cardiovasc Transl Res; 2015 Apr; 8(3):198-207. PubMed ID: 25896492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION.
    Villa C; Auerbach SR; Bansal N; Birnbaum BF; Conway J; Esteso P; Gambetta K; Hall EK; Kaufman BD; Kirmani S; Lal AK; Martinez HR; Nandi D; O'Connor MJ; Parent JJ; Raucci FJ; Shih R; Shugh S; Soslow JH; Tunuguntla H; Wittlieb-Weber CA; Kinnett K; Cripe L
    Pediatr Cardiol; 2022 Jun; 43(5):977-985. PubMed ID: 35024902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin converting enzyme inhibitors and beta-blockers in African Americans with heart failure.
    McCullough PA; Philbin EF; Spertus JA; Sandberg KR; Kaatz S
    Ethn Dis; 2003; 13(3):331-6. PubMed ID: 12894957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.